Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
The Quarterly Journal of Medicine
|
March 1, 1992
Therapeutic potential of botulinum toxin in neurological disorders
C E Clarke
The Practitioner
|
August 7, 1999
Managing early Parkinson's disease
C E Clarke
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1997
Movement Disorders Cochrane Collaborative Review Group
C E Clarke, C Sampaio
Lancet (London, England)
|
December 14, 2002
Dopamine agonist monotherapy in Parkinson's disease
C E Clarke, M Guttman
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 14, 2000
Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease
C E Clarke, P Davies
European Journal of Neurology
|
January 3, 2001
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy
C E Clarke, M Lowry
European Journal of Neurology
|
January 11, 2002
Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes
C E Clarke, M Lowry
Parkinsonism & Related Disorders
|
November 26, 2013
Reasons for Parkinson's disease admissions in a large inner city hospital
A Arasalingam, C E Clarke
Praxis
|
July 13, 2001
[Parkinson disease]
A P Moore, C E Clarke
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
The Quarterly Journal of Medicine
|
March 1, 1992
Therapeutic potential of botulinum toxin in neurological disorders
C E Clarke
The Practitioner
|
August 7, 1999
Managing early Parkinson's disease
C E Clarke
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1997
Movement Disorders Cochrane Collaborative Review Group
C E Clarke, C Sampaio
Lancet (London, England)
|
December 14, 2002
Dopamine agonist monotherapy in Parkinson's disease
C E Clarke, M Guttman
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 14, 2000
Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease
C E Clarke, P Davies
European Journal of Neurology
|
January 3, 2001
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy
C E Clarke, M Lowry
European Journal of Neurology
|
January 11, 2002
Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes
C E Clarke, M Lowry
Parkinsonism & Related Disorders
|
November 26, 2013
Reasons for Parkinson's disease admissions in a large inner city hospital
A Arasalingam, C E Clarke
Praxis
|
July 13, 2001
[Parkinson disease]
A P Moore, C E Clarke
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
Page
of 11